MP49 - MP49: Bladder Cancer: Invasive I

Poster Presenter(s)

• UA

  Umberto Anceschi
• 

  Aldo Brassetti, MD

  Regina Elena Hospital, National Cancer Institute
• HC

  Heather Chalfin
• 

  Ahmed Elsayed, MD

  Research Fellow
  Roswell Park Comprehensive Cancer Center

  PDF Poster Slides and Audio
• 

  Ahmed Harraz, MD,MS,FRCS

  Associate professor of urology
  Urology and Nephrology Center, Mansoura University, Egypt

  PDF Poster Slides and Audio
• HH

  Hirotaka Horiguchi
• YK

  Yansheng Kan
• PK

  Preston Kerr, MD

  University of Texsas Medical Branch Galveston

  PDF Poster Slides and Audio
• RM

  Riccardo Mastroianni, MD

  "Sapienza" University

  PDF Poster Slides and Audio
• KO

  Koichiro Ogihara, MD,PhD

  Keio University School of Medicine

  PDF Poster Slides
• 

  Manish Pradhan, MBBS,MS

  MCh resident
  TU Teaching Hospital

  PDF Poster Slides and Audio
• RS

  Ryan Speir, MD

  MD
  UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES

  PDF Poster Slides and Audio
• TT

  Takashi Tamiya
• 

  Toshiaki Tanaka, MD,Phd

  Sapporo Medical University

  PDF Poster Slides and Audio
• GT

  Gabriele Tuderti, MD

  PDF Poster Slides and Audio
• 

  Malte Vetterlein, MD

  University Medical Center Hamburg-Eppendorf
• KW

  Keitaro Watanabe

Presentations:

• 7:00 AM – 9:00 AM

  MP49-01: Impact of Diagnosing Urologists and Hospitals on Use of Radical Cystectomy
  Preston Kerr, MD
• 7:00 AM – 9:00 AM

  MP49-02: The Effect of Surgical Complexity on Perioperative Outcomes of Robot-Assisted Radical Cystectomy
  Ahmed Elsayed, MD – Roswell Park Comprehensive Cancer Center
• 7:00 AM – 9:00 AM

  MP49-03: Circulating Tumor Cell Subtypes and Baseline T-cell Population as Prognostic Biomarkers to Combination Therapy with Cabozantinib, Nivolumab, and Ipilimumab in Metastatic Genitourinary Cancer Patients
  Heather Chalfin
• 7:00 AM – 9:00 AM

  MP49-04: Long-term oncologic outcomes following robot-assisted radical cystectomy with totally intracorporeal urinary diversion: a multicenter study
  Aldo Brassetti, MD – Sant Andrea Hospital, La Sapienza University, Rome, Italy
• 7:00 AM – 9:00 AM

  MP49-05: Pretreatment absolute monocyte count is a novel biomarker for predicting worse clinical outcome in chemo-resistant urothelial carcinoma patients treated with pembrolizumab
  Koichiro Ogihara, MD,PhD – Keio University School of Medicine, Department of
• 7:00 AM – 9:00 AM

  MP49-06: Effect of neoadjuvant chemotherapy on Ki67 and PDL1 expression in muscle invasive bladder cancer
  Hirotaka Horiguchi
• 7:00 AM – 9:00 AM

  MP49-07: Making the Case for Ureterocutaneostomy Following Radical Cystectomy in the Elderly: a Comparative Assessment of Different Urinary Diversions According to the Updated EAU Guidelines of Standardized Complication Reporting
  Malte W. Vetterlein, MD – University Medical Center Hamburg-Eppendorf
• 7:00 AM – 9:00 AM

  MP49-08: Specific gene set scores in prognostic prediction of muscle invasive bladder cancer
  Yansheng Kan
• 7:00 AM – 9:00 AM

  MP49-09: Correlation between immune-related adverse events spectrum and prognosis in patients with advanced urothelial cancer treated with pembrolizumab.
  Takashi Tamiya
• 7:00 AM – 9:00 AM

  MP49-10: The influence of ileal conduit-related complications on the long-term renal function after radical cystectomy
  Ahmed Mohamed Harraz, MD,MS,FRCS
• 7:00 AM – 9:00 AM

  MP49-11: Global cost assessment of Robot assisted versus open radical cystectomy: hospital costs and patients' perspectives, two sides of the moon
  Riccardo Mastroianni, MD
• 7:00 AM – 9:00 AM

  MP49-12: Recurrences after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
  Ahmed Elsayed, MD – Roswell Park Comprehensive Cancer Center
• 7:00 AM – 9:00 AM

  MP49-13: Safety and efficacy of Monopolar vs Bipolar Transurethral resection of bladder tumor
  Manish Man Pradhan, MBBS,MS – TU Teaching Hospital
• 7:00 AM – 9:00 AM

  MP49-14: Functional outcomes of Robot-Assisted Radical Cystectomy with Intracorporeal Padua Ileal Neobladder
  Gabriele Tuderti, MD – "Regina Elena" National Cancer Institute, Dept. of
• 7:00 AM – 9:00 AM

  MP49-15: Development of a nomogram to predict achievement of trifecta outcomes in patients receving Robot-Assisted Radical Cystectomy with intracorporeal orthotopic neobladder
  Umberto Anceschi
• 7:00 AM – 9:00 AM

  MP49-16: Who could be effectively treated with adjuvant chemotherapy among pathologically node positive muscle invasive bladder cancer patients treated with radical cystectomy? : A multicenter cohort study adjusted by propensity score matching
  Keitaro Watanabe
• 7:00 AM – 9:00 AM

  MP49-17: Management of hydronephrosis after radical cystectomy and urinary diversion for bladder cancer
  Toshiaki Tanaka, MD,Phd – Sapporo Medical University
• 7:00 AM – 9:00 AM

  MP49-18: EARLY COMPLICATIONS AS A RESULT OF INDIANA POUCH URINARY DIVERSION: A 7 YEAR EXPERIENCE
  Ryan W. Speir, MD – IU SCHOOL OF MEDICINE, DEPARTMENT OF UROLOGY
• 7:00 AM – 9:00 AM

  MP49-19: Late hospital readmission after radical cystectomy and ileal conduit urinary diversion: a time-dependent analysis in 1400 patients
  Ahmed Mohamed Harraz, MD,MS,FRCS
• 7:00 AM – 9:00 AM

  MP49-20: Longitudinal assessment of health related quality of life: head to head comparison between robot-assisted and open radical cystectomy from a single center randomised controlled trial
  Riccardo Mastroianni, MD